InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-6.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Woody Joseph Fralin, Chief Executive Officer. Insider active across 2 companies, notably Avanos Medical, INC.. In total, 24 reports have been published. Breakdown: 9 buys · 0 sell. Total volume traded: €108k. History available since 17 March 2021. The latest transaction was filed on 3 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations24 total
5,200 sharesCommon StockSEC:0001193125-26-266397:0
Ideal exit: 6 Mar 2027 (T+270)
5,000 sharesCommon StockSEC:0001193125-26-263968:1
Ideal exit: 6 Mar 2027 (T+270)
5,000 sharesCommon StockSEC:0001193125-26-263968:0
Ideal exit: 6 Mar 2027 (T+270)
5,000 shares@ US$4.09990.018% mcap16.3% of flowCommon StockSEC:0001709989-26-000011:0
Ideal exit: 28 Feb 2027 (T+270)
5,000 shares@ US$4.08990.018% mcap16.2% of flowCommon StockSEC:0001709989-26-000011:1
Ideal exit: 28 Feb 2027 (T+270)
40,547 sharesCommon StockSEC:0001709989-26-000008:0
22,214 sharesCommon StockSEC:0001709989-26-000008:1
5,000 shares@ US$4.340.018% mcap25.5% of flowCommon StockSEC:0001709989-26-000006:0
Ideal exit: 26 Feb 2027 (T+270)
5,000 shares@ US$4.260.017% mcap25.1% of flowCommon StockSEC:0001709989-26-000006:1
Ideal exit: 26 Feb 2027 (T+270)
5,000 shares@ US$4.18020.017% mcap24.6% of flowCommon StockSEC:0001709989-26-000006:2
Ideal exit: 27 Feb 2027 (T+270)
5,000 shares@ US$4.20710.017% mcap24.8% of flowCommon StockSEC:0001709989-26-000006:3
Ideal exit: 27 Feb 2027 (T+270)
11,827 shares@ US$15.301.8% of flowCommon StockSEC:0001606498-25-000040:0
32,158 shares0Common StockSEC:0001606498-25-000033:0
15,821 shares0Common StockSEC:0001606498-24-000049:0
7,095 shares@ US$19.091.3% of flowCommon StockSEC:0001606498-24-000049:1
26,670 shares@ US$19.094.9% of flowCommon StockSEC:0001606498-24-000049:2
137,147 shares@ US$19.1425.4% of flowCommon StockSEC:0001606498-24-000036:0
8,431 shares@ US$18.761.5% of flowCommon StockSEC:0001606498-24-000024:0
57,256 shares@ US$23.9713.1% of flowCommon StockSEC:0001606498-23-000044:0
86,547 shares0Common StockSEC:0001606498-23-000024:0
8,314 shares@ US$29.622.4% of flowCommon StockSEC:0001606498-23-000024:1
80,933 shares0Common StockSEC:0001606498-22-000031:0
59,477 shares@ US$47.290.20% mcap50.0% of flowCommon StockSEC:0001606498-21-000049:0
59,477 shares@ US$47.2924.8% of flowCommon StockSEC:0001606498-21-000049
24 of 24 declarations
About Woody Joseph Fralin
Joseph Fralin Woody is the Chief Executive Officer of AVANOS MEDICAL, INC. He leads the company by overseeing all operations and defining the overall strategy. His role is essential in ensuring the company's growth and innovation in the medical sector. Through his leadership, he guides the team toward achieving business objectives while ensuring regulatory compliance and stakeholder satisfaction.
